Medtronic stock forecast the latest medtronic stock forecast

The latest medtronic stock forecast cites robust demand in cardiac rhythm and neuro products, pushing projected 12-month target to $ With a high three-year median payout ratio of 87% (implying that 13% of the profits are retained), most of Medtronic's profits are being paid to shareholders, which explains the company's shrinking earnings. With only a little being reinvested into the business, earnings growth would obviously be low or non-existent. Before you consider Medtronic, you'll want to hear this. The recent medtronic stock forecast revision by major banks sets a 12-month range of $88–$95, responding to competitive cost controls and operational efficiency improvements.